Upload
catalina-busbee
View
215
Download
0
Embed Size (px)
Citation preview
Confidential 110228PH001MG.PPT/008-17-49183 5/2005
Pharmaceutical Coalition
Transparency in PharmaceuticalPurchasing Solutions (TIPPS)Transparency in PharmaceuticalPurchasing Solutions (TIPPS)
October 10, 2007
Confidential 210228PH001MG.PPT/008-17-49183 5/2005
Today’s Discussion
– TIPPS Standards & Objectives
– Review of 2008 Bidding Requirements
– Presentation by Robert I. Garis, Ph. D.
– Future of AWP
– Lunch
– Recap of 2008 TIPPS Process
– Refining TIPPS Standards and Coalition Objectives for 2009
– Update of Compliance Project
Confidential 310228PH001MG.PPT/008-17-49183 5/2005
Coalition Leadership & Staff
Sidney BanwartVice President, Human Services Division, Caterpillar, Inc.Chairman, Pharmaceutical Purchasing Coalition
Todd BispingCaterpillar, Inc.
Marisa MiltonHR Policy Association
Steve WetzellHealth Care Policy Roundtable
Confidential 410228PH001MG.PPT/008-17-49183 5/2005
Hewitt’s Project Support
Joshua Golden National TIPPS Project Leader
Kristin Begley, Pharm. D.Senior Pharmacy Consultant
Confidential 510228PH001MG.PPT/008-17-49183 5/2005
ACS General Dynamics Northwestern MutualALCOA Inc. General Mills PepsiCo, IncorporatedApple Computer HCA Inc. PPG Industries, IncArmstrong World Industries Hewitt Associates Prudential FinancialAT&T, Inc. Hilton Hotels Corporation Quest Diagnostics BAE Systems The Home Depot, USA Inc. Rolls-Royce North AmericaCaterpillar Inc. Honeywell International Inc. Shell Oil CompanyCinergy Corporation IBM Corporation Sodexho, Inc.Cox Enterprises, Inc. International Paper Starbucks CorporationDTE Energy Company Johnson Controls, Inc. Sunoco, Inc.Eaton Corporation KeyCorp Swift Transportation Co.EMC Corporation Liberty Mutual Insurance TAP Pharmaceutical ProductsEmerson Electric Company Lowe’s Companies, Inc. Temple-InlandExelon Corporation Lucent Technologies Texas InstrumentsFederal-Mogul Corporation Maersk TXU Business ServicesFirst Data Corporation Marathon Petroleum University of Missouri SystemFMC Corporation Marathon Oil Corporation United TechnologiesFMC Technologies McDonald’s Corporation Verizon CommunicationsFord Motor Corporation Motorola, Inc. Verizon WirelessFPL Group Inc. Northrup Grumman The Walt Disney Company
TIPPS Coalition Member Companies
Confidential 610228PH001MG.PPT/008-17-49183 5/2005
Aetna Pharmacy Management
Blue Cross and Blue Shield of Alabama
CVS Caremark
Catalyst Rx, A HealthExtras Company
CIGNA Pharmacy Management
Express Scripts, Inc.
Humana
Medco Health Solutions, Inc.
Prime Therapeutics, LLC
RESTAT PBM LLC
SXC Health Solutions, Inc.
Walgreens Health Initiatives, Inc.
WellPoint NextRx
Pharmaceutical Coalition/TIPPS 2008 Certified PBMs
Confidential 710228PH001MG.PPT/008-17-49183 5/2005
Washington Post Ad
10228PH001MG.PPT/008-17-49183 5/2005
Review of TIPPS Standards and Coalition Objectives
Confidential 910228PH001MG.PPT/008-17-49183 5/2005
The Pharmaceutical Coalition
Primary Objective:
Leverage the combined purchasing volume of Coalition to change the way pharmaceutical products are purchased
– create price transparent environment to encourage competition and consumerism
– align incentives of PBMs with employers and patients
– establish a platform for value-based purchasing
– drive business to certified PBMs that agree with principles
Confidential 1010228PH001MG.PPT/008-17-49183 5/2005
Overview of Bidding Requirements
Bidding Requirements Have Been Streamlined
– Six principle bidding requirements fundamental in the selection criteria
• Format has been streamlined from nine requirements in 2006
• Still designed to capture the ultimate in financial disclosure and service capability, and allow for a true partnership between a PBM and client
Confidential 1110228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 1
Acquisition Cost for All Retail Claim Payments
– Charge the Participating Group no more than the amount that you pay the pharmacies in your retail network for each claim dispensed
– Includes all brand and generic drugs.
Confidential 1210228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 2
Acquisition Cost Basis for All Mail Service Claim Payments
– Charge no more than the acquisition cost of drugs at the mail order pharmacy, plus a dispensing fee.
– Acquisition cost is defined as either:
• actual inventoried per unit cost (AAC), or
• published Wholesale Acquisition Cost (WAC)
– Agree to utilize a MAC list to determine the Participating Group’s cost for any drugs that do not have an associated WAC price
Confidential 1310228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 3
Pass-Through of 100% of All Pharmaceutical Manufacturer Revenue
– Pass through 100% of any and all formulary rebates, market-share rebates, and other rebate revenue that the Participating Group’s utilization enables you to earn.
– Includes Rebate Administrative Fees, Data Sale Revenue, and Compliance/Adherence program revenue
Confidential 1410228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 4
Specialty Pharmacy Transparency
– Charge no more than the acquisition cost of drugs at the specialty mail order pharmacy, plus a dispensing fee.
– Pass through any and all pharmaceutical manufacturer revenue.
– Provide dose optimization and consolidation programs, where appropriate.
– Provide case management for critical disease states (and not build cost of programs into ingredient cost)
– Offer a tool to enable cross-walk billing (i.e., J-Code to NDC conversion)
Confidential 1510228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 5
Plan Management/Consumer Engagement – Apply rebate on a per-unit basis specific to NDC-11 at the point of sale
(at client’s discretion).
– provide members with decision support tools:
• web-based formulary lookup tool
• web-based drug price comparison tool, with retail pharmacy pricing comparison
• web-based or letter-based utilization summary tool that identifies member cost-share savings opportunities
– Offer financial performance guarantees to support effective utilization management, by therapeutic class.
• Penalties to be assessed on a dollar-for-dollar basis
Confidential 1610228PH001MG.PPT/008-17-49183 5/2005
Bidding Requirement 6
Comprehensive Audit & Disclosure Rights – Offer full audit rights
• Audits of Claims/Utilization Data
• Audits of Retail Network Contracts
• Audits of Rebate Arrangements
• Audits of Clinical Savings Criteria
– No limitation to specific list of audit firms (“mutually agreeable”)
– Allow self-audit by client
– Provide claims data with all financial fields
– Outsourcing vendors must also allow audits
Confidential 1710228PH001MG.PPT/008-17-49183 5/2005
Exclusion Criteria
The following criteria are grounds for exclusion from TIPPS certification:
– PBM does not agree to all 2008 bidding requirements
– PBM does not complete an RFP response, or submits an incomplete RFP response
– PBM’s fee exhibit contradicts their RFP response
Confidential 1810228PH001MG.PPT/008-17-49183 5/2005
If a vendor outsources ANY core functionality that is relevant to the bidding requirements, that vendor must provide documentation that the outsourced provider ALSO meets the certification criteria.
– Includes outsourced mail service, rebate administration, specialty drug management, etc.
– This documentation MUST include the Audit Rights bidding requirement – audit rights must extend to the third-party outsourced provider
– Letter templates provided with the RFP for each outsourced functionality
Outsourced Services
10228PH001MG.PPT/008-17-49183 5/2005
Robert I. Garis, Ph.D. “The HR Executive: Optimal Pricing in
Pharmacy Benefit Programs”
10228PH001MG.PPT/008-17-49183 5/2005
Future of AWP
10228PH001MG.PPT/008-17-49183 5/2005
Lunch
10228PH001MG.PPT/008-17-49183 5/2005
Recap of 2008 Certification Process
Confidential 2310228PH001MG.PPT/008-17-49183 5/2005
Request for Proposals (RFPs)
RFP process went as planned:
– RFP distributed broadly to all interested PBMs (based on PBM request)
– Core TIPPS Bidding Requirements
– Additional Questions on Topics of Interest
– Outsourcing Documentation Requirements
– Certification proposals received from 16 PBMs
– Preliminary certification granted to 14 PBMs
– Fee Exhibits released, evaluated
– Final Certification granted to 13 PBMs
Confidential 2410228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Initial Proposal Review - Process
– Initial proposal review conducted with Coalition on July 12th (telephonic meeting)
– “Preliminary Certification” status determined for each PBM vendor
– Review included a line-item confirmation of all bidding requirement details
– Material deviations from bidding requirements identified
– Follow-up conducted to resolve deviations where possible/appropriate
– Vendors receiving Preliminary Certification were issued a fee exhibit for final approval/certification
Confidential 2510228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Initial Proposal Review - Methodology
“Green Light”Vendor meets all certification criteria, or criteria deviations are likely to be satisfactorily resolved. All necessary outsourcing documentation has been provided.
“Yellow Light”Vendor has significant deviations which may or may not be resolved. Outsourcing documentation may be outstanding.
“Red Light”Vendor’s current response includes serious deviations that are not likely to be satisfactorily resolved.
Confidential 2610228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Initial Proposal Review - Outcome
“Green Light” “Yellow Light” “Red Light”
Aetna
Caremark
Catalyst Rx
CIGNA
Express-Scripts
Humana
Medco
Walgreens Health Initiatives
Wellpoint NextRx
BCBS Alabama
Prime Therapeutics
HealthTrans
RESTAT
SXC Rx
MedImpact
Rx America
Confidential 2710228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Red Light Bidders – Issues
– MedImpact
• Refused to provide documentation for outsourced mail service and specialty vendors
– Rx America
• Documentation not provided for outsourced specialty functionality
• Could not provide acquisition cost basis for specialty drugs
• Some contracts with network pharmacies and pharmaceutical companies preclude vendor from allowing full audit rights
Confidential 2810228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Yellow Light Bidders – Most Common Issue
– Missing documentation for outsourced arrangements (with vendor working to provide documentation)
• Outsourced specialty vendor
• Outsourced mail service vendor
• Outsourced rebate contracting
– Final certification was contingent on receipt of documentation
– All Yellow & Green Light vendors provided documentation by final certification deadline
Confidential 2910228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
All Bidders – Other Observations
– Seven (7) vendors did not currently offer POS rebate administration (agreed to develop within 6 months upon request)
– Three (3) vendors would not pass-through revenue from Data Aggregation (but agreed to allow client to opt-out of these programs)
– Two (2) vendors did not currently offer acquisition cost basis for mail service (agreed to develop within 6 months upon request)
Confidential 3010228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
HealthTrans – Withdrawal of Submission
“Thank you for allowing HealthTrans to participate in the HRPA/TIPPS 2008 certification process. Please accept this letter as notification that HealthTrans, after careful consideration, has decided not to proceed with certification this year.
As a pioneer and a continuing leader in the area of not only transparency, but also a differentiating business model that reflects our philosophy of visibility, value and validation we could not agree more with the principles espoused by HRPA.
We appreciate the opportunities that have emerged from our relationship with both Hewitt and HRPA over the recent past, and HealthTrans looks forward to working with you in the future to further the interests of both clients and consumers.” (HealthTrans)
Confidential 3110228PH001MG.PPT/008-17-49183 5/2005
Review of RFP Responses
Final Outcome
– Thirteen (13) PBM vendors were granted certification:
• Aetna Pharmacy Management
• BlueCross and Blue Shield of Alabama
• CVS Caremark
• Catalyst Rx, A HealthExtras Company
• Cigna Pharmacy Management
• Express Scripts
• Humana Pharmacy
• Medco Health Solutions, Inc.
• Prime Therapeutics LLC
• RESTAT
• SXC Health Solutions, Inc.
• Walgreens Health Initiatives
• WellPoint NextRx
Confidential 3210228PH001MG.PPT/008-17-49183 5/2005
AWP AlternativesWith the possible withdrawal of AWP from the marketplace as an available reference price, please describe your organization’s current “plan of action” as it pertains to pursuing alternative pricing metrics.
– “Although none of the options meet all the requirements [of a replacement metric], the WAC has the least amount of challenges surrounding it...”
– “Medi-Span maintains their position that their process for deriving AWP will remain unchanged...”
– “No change is without its challenges; however [we believe] that WAC is the right alternative…”
– “[Our] current choice is WAC, but AMP is also being evaluated…”
RFP - Additional Topics of Interest
Confidential 3310228PH001MG.PPT/008-17-49183 5/2005
Follow-On (Generic) BiologicsWhat specific actions is your organization taking to promote the present or future availability of follow-on (generic) biologics?
– “CIGNA Pharmacy Management is involved with the coordinated efforts of PCMA and AHIP in lobbying and promoting FDA action to approve the availability of generic biologics.“
– “Express Scripts is among the leaders of the legislative initiative to develop an FDA pathway for follow-on biologics... and published a financial model of the potential savings of such a pathway.”
– “Aetna is FOR a regulatory pathway to allow FDA to approve generic biopharmaceuticals… Aetna is OPPOSED to legislation that messes with patents or directs the FDA as to what to review, how to review it and what to decide (we don't want to pre-judge the science).”
RFP - Additional Topics of Interest
Confidential 3410228PH001MG.PPT/008-17-49183 5/2005
Fiduciary ResponsibilityParticipating Groups in the TIPPS Coalition may wish to have their PBM serve in various fiduciary roles for their plan. Please state your willingness to act as fiduciary in the following capacities: First Level Appeals, Second/Third Level Appeals, Final Appeal Decision, Clinical (Formulary) Management, Named Co-Fiduciary for Overall Plan Administration, Named Sole Fiduciary for Overall Plan Administration.
– Several vendors (Aetna, BCBSAL, MedImpact) agreed to serve as fiduciary in all capacities listed
– Several vendors agreed to accept most or all responsibilities after a case-by-case consideration
– Many vendors limited their fiduciary roles
– Limited to first-level appeals and clinical/formulary management
– Would not accept responsibility for medical necessity determinations or overall plan administration
– Many vendors offer third-party services to support the appeals process
RFP - Additional Topics of Interest
10228PH001MG.PPT/008-17-49183 5/2005
Evaluating TIPPS Compliance and Savings
10228PH001MG.PPT/008-17-49183 5/2005
Refining TIPPS Standards and Coalition Objectives for 2009
10228PH001MG.PPT/008-17-49183 5/2005
Compliance Project Update